–°–ø—ñ–Ω–∞–ª—å–Ω–∞ –º'—è–∑–æ–≤–∞ –∞—Ç—Ä–æ—Ñ—ñ—è (–°–ú–ê), —á–∞—Å—Ç–∏–Ω–∞ –¥—Ä—É–≥–∞: –ª—ñ–∫—É–≤–∞–Ω–Ω—è.
–î–ª—è –∫—Ä–∞—â–æ–≥–æ —Ä–æ–∑—É–º—ñ–Ω–Ω—è —Ä–µ–∫–æ–º–µ–Ω–¥—É—é –ø–æ–ø–µ—Ä–µ–¥–Ω—ñ–π –¥–æ–ø–∏—Å –ø—Ä–æ –°–ú–ê: –ª—ñ–Ω–∫.
–†–∞–Ω—ñ—à–µ –ø—Ä–∏ 5q —Ñ–æ—Ä–º—ñ –°–ú–ê, —è–∫–∞ –ø–æ–≤'—è–∑–∞–Ω–∞ —ñ–∑ –∑–Ω–∏–∂–µ–Ω–Ω—è–º —á–∏ –≤—Ç—Ä–∞—Ç–æ—é –µ–∫—Å–ø—Ä–µ—Å—ñ—ó  SMN1, —ñ—Å–Ω—É–≤–∞–ª–æ –ª–∏—à–µ —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–Ω–µ –ª—ñ–∫—É–≤–∞–Ω–Ω—è, –ø—Ä–æ—Ç–µ –≤ –ø–æ–ø–µ—Ä–µ–¥–Ω—ñ —Ä–æ–∫–∏ –±—É–ª–∏ c—Ö–≤–∞–ª–µ–Ω—ñ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∏, –∑–¥–∞—Ç–Ω—ñ –º–æ–¥–∏—Ñ—ñ–∫—É–≤–∞—Ç–∏ –ø–µ—Ä–µ–±—ñ–≥ —Ö–≤–æ—Ä–æ–±–∏.
üíâ Nusinersen (–∫–æ–º–µ—Ä—Ü—ñ–π–Ω–∞ –Ω–∞–∑–≤–∞: Spinraza) ‚Äî —Ü–µ –ø–µ—Ä—à–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª—ñ–∫—É–≤–∞–Ω–Ω—è –°–ú–ê, —è–∫–∏–π –æ—Ç—Ä–∏–º–∞–≤ –∞–≤—Ç–æ—Ä–∏–∑–∞—Ü—ñ—é FDA (2016 —Ä—ñ–∫) —Ç–∞ EMA (2017 —Ä—ñ–∫).
–†–∞–Ω—ñ—à–µ –±—É–≤ –≤—ñ–¥–∫—Ä–∏—Ç–∏–π intronic splicing silencer N1 (ISS-N1), —Ñ–∞–∫—Ç–æ—Ä, —è–∫–∏–π –ø—Ä–∏–∑–≤–æ–¥–∏—Ç—å –¥–æ —Å–ø–ª–∞–π—Å–∏–Ω–≥—É —Å—å–æ–º–æ–≥–æ –µ–∫–∑–æ–Ω—É –ø—Ä–µ-–º–†–ù–ö –≥–µ–Ω—É SMN2, —á–µ—Ä–µ–∑ —â–æ —Ü–µ–π –≥–µ–Ω —Å–∞–º –Ω–µ –º–æ–∂–µ –ø—Ä–æ–¥—É–∫—É–≤–∞—Ç–∏ –¥–æ—Å—Ç–∞—Ç–Ω—å–æ—ó –∫—ñ–ª—å–∫–æ—Å—Ç—ñ —Ñ—É–Ω–∫—Ü—ñ–æ–Ω–∞–ª—å–Ω–æ–≥–æ –±—ñ–ª–∫–∞ SMN.
Nusinersen —î –∞–Ω—Ç–∏—Å–µ–Ω—Å –æ–ª—ñ–≥–æ–Ω—É–∫–ª–µ–æ—Ç–∏–¥–æ–º –¥–æ ISS-N1, —á–µ—Ä–µ–∑ –π–æ–≥–æ –±–ª–æ–∫—É–≤–∞–Ω–Ω—è —Å—å–æ–º–∏–π –µ–∫–∑–æ–Ω –∑–∞–ª–∏—à–∞—î—Ç—å—Å—è —É —Å–∫–ª–∞–¥—ñ –º–†–ù–ö, —è–∫–∞ –ø–æ—Ç—ñ–º —Ç—Ä–∞–Ω—Å–ª—é—î—Ç—å—Å—è —É –ø–æ–≤–Ω–æ—Ü—ñ–Ω–Ω–∏–π SMN.
üíâ Onasemnogene abeparvovec (–∫–æ–º–µ—Ä—Ü—ñ–π–Ω–∞ –Ω–∞–∑–≤–∞: Zolgensma) ‚Äî —Ü–µ –≥–µ–Ω–Ω–∞ —Ç–µ—Ä–∞–ø—ñ—è, –∞–≤—Ç–æ—Ä–∏–∑–æ–≤–∞–Ω–∞ FDA (2019 —Ä—ñ–∫) —Ç–∞ —è–∫–∞ —Ä–æ–∑–≥–ª—è–¥–∞—î—Ç—å—Å—è EMA (–ª—ñ–Ω–∫).
–ü—Ä–µ–ø–∞—Ä–∞—Ç —î –≥–µ–Ω–µ—Ç–∏—á–Ω–∏–º –≤–µ–∫—Ç–æ—Ä–æ–º, —â–æ “ë—Ä—É–Ω—Ç—É—î—Ç—å—Å—è –Ω–∞ –∞–¥–µ–Ω–æ–∞—Å–æ—Ü—ñ–π–æ–≤–∞–Ω–æ–º—É –≤—ñ—Ä—É—Å—ñ, —ñ –¥–æ—Å—Ç–∞–≤–ª—è—î —É –∫–ª—ñ—Ç–∏–Ω–∏ –∫–æ–ø—ñ—é –≥–µ–Ω–∞, –∑–¥–∞—Ç–Ω—É –ø—Ä–æ–¥—É–∫—É–≤–∞—Ç–∏ —Ñ—É–Ω–∫—Ü—ñ–æ–Ω–∞–ª—å–Ω–∏–π SMN.
–¶–µ–π –≤–µ–∫—Ç–æ—Ä –Ω–µ —î –ø–∞—Ç–æ–≥–µ–Ω–Ω–∏–º –¥–ª—è –ª—é–¥–∏–Ω–∏ —Ç–∞ –º–∞—î —Ç—Ä–æ–ø—ñ–∑–º –¥–æ –Ω–µ–π—Ä–æ–Ω—ñ–≤.
–ß–∏ —î –ª—ñ–∫—É–≤–∞–Ω–Ω—è –°–ú–ê –∑–∞–∫—Ä–∏—Ç–∏–º –ø–∏—Ç–∞–Ω–Ω—è–º?
–ù–∞ –∂–∞–ª—å, –Ω—ñ.
–ï—Ñ–µ–∫—Ç–∏–≤–Ω—ñ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ñ–≤ –Ω–µ —î —Å—Ç–æ–≤—ñ–¥—Å–æ—Ç–∫–æ–≤–æ—é, –Ω–∞–π–µ—Ñ–µ–∫—Ç–∏–≤–Ω—ñ—à—ñ –≤–æ–Ω–∏ –ø—Ä–∏ —Ä–∞–Ω–Ω—å–æ–º—É –ø—Ä–∏–∑–Ω–∞—á–µ–Ω–Ω—ñ.
–î–ª—è –¥—ñ—Ç–µ–π –≤—ñ–¥ 12 —Ä–æ–∫—ñ–≤ –ø—Ä–∏–∑–Ω–∞—á–µ–Ω–Ω—è Nusinersen –º–æ–∂–µ –º–∞—Ç–∏ –ø–µ—Ä–µ–≤–∞–≥–∏, –µ—Ñ–µ–∫—Ç–∏–≤–Ω—ñ—Å—Ç—å —ñ–Ω—à–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –¥–ª—è –¥—ñ—Ç–µ–π –≤—ñ–¥ –¥–≤–æ—Ö —Ä–æ–∫—ñ–≤ –Ω–µ–≤—ñ–¥–æ–º–∞.
–ü–µ—Ä—à–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤–∏–º–∞–≥–∞—î –≤–≤–µ–¥–µ–Ω–Ω—è —Ä–∞–∑ –Ω–∞ —á–æ—Ç–∏—Ä–∏ –º—ñ—Å—è—Ü—ñ —ñ–Ω—Ç—Ä–∞—Ç–µ–∫–∞–ª—å–Ω–æ –ø—Ä–æ—Ç—è–≥–æ–º —É—Å—å–æ–≥–æ –∂–∏—Ç—Ç—è, –æ–±–∏–¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ñ –º–∞—é—Ç—å —Å–µ—Ä–π–æ–∑–Ω—ñ –ø–æ–±—ñ—á–Ω—ñ –µ—Ñ–µ–∫—Ç–∏, –∑–æ–∫—Ä–µ–º–∞ —É spinraza ‚Äì –Ω–µ—Ñ—Ä–æ—Ç–æ–∫—Å–∏—á–Ω—ñ—Å—Ç—å (–ª—ñ–Ω–∫), —É zolgensma ‚Äì –≥–æ—Å—Ç—Ä–µ —É—Ä–∞–∂–µ–Ω–Ω—è –ø–µ—á—ñ–Ω–∫–∏ (–ª—ñ–Ω–∫).
–¶—ñ–Ω–∞ spinraza –∑–∞ –æ–¥–Ω—É –¥–æ–∑—É ‚Äì –ø—Ä–∏–±–ª–∏–∑–Ω–æ $125,000, —Ü—ñ–Ω–∞ zolgensma –∑–∞ —î–¥–∏–Ω—É –Ω–µ–æ–±—Ö—ñ–¥–Ω—É –¥–æ–∑—É ‚Äì –ø–æ–Ω–∞–¥ $2,000,000.
–ü—Ä–æ—Ç–µ —Ü–µ —î–¥–∏–Ω–µ –¥–æ—Å—Ç—É–ø–Ω–µ –ª—ñ–∫—É–≤–∞–Ω–Ω—è, —è–∫–µ –º–æ–∂–µ –∑–∞–ø–æ–±—ñ–≥—Ç–∏ —Ä–æ–∑–≤–∏—Ç–∫—É —Å–∏–º–ø—Ç–æ–º—ñ–≤ —Ö–≤–æ—Ä–æ–±–∏.
üñ• –ó–≥—ñ–¥–Ω–æ –∑ clinicaltrials.gov, –Ω–∞—Ä–∞–∑—ñ –∞–∫—Ç–∏–≤–Ω—ñ 11 –¥–æ—Å–ª—ñ–¥–∂–µ–Ω—å —É —Ñ–∞–∑—ñ
–Ü —Ç–∞ –Ü–Ü, —Ç–æ–º—É, –º–æ–∂–ª–∏–≤–æ, —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–Ω–∏—Ö –∑–∞—Å–æ–±—ñ–≤ —É –Ω–∞–π–±–ª–∏–∂—á—ñ —Ä–æ–∫–∏ —Å—Ç–∞–Ω–µ –±—ñ–ª—å—à–µ.
–î–æ —Ç–æ–≥–æ –∂, —Ü—ñ–Ω–∞ –Ω–∞ –Ω–∞—è–≤–Ω—É —Ç–µ—Ä–∞–ø—ñ—é, —Å–∫–æ—Ä—ñ—à –∑–∞ –≤—Å–µ, –∑–Ω–∏–∑–∏—Ç—å—Å—è –∑ —á–∞—Å–æ–º.
–ü—Ä–æ—Ç–µ, –º–æ–∂–ª–∏–≤–æ, —Ü–µ —Å—Ç–∞–Ω–µ—Ç—å—Å—è –ª–∏—à–µ –ø—ñ—Å–ª—è –∑–∞–≤–µ—Ä—à–µ–Ω–Ω—è —Ç–µ—Ä–º—ñ–Ω—É –¥—ñ—ó –ø–∞—Ç–µ–Ω—Ç—É.
–î–∂–µ—Ä–µ–ª–∞:
1. Olaf A Bodamer Spinal muscular atrophy.
UpToDate 2019
http://bit.ly/2rX9Z0X
2. Eric W. Ottesen ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy.
Transl Neurosci.
2017; 8: 1‚Äì6
http://bit.ly/2PsQDtI
#–≥–µ–Ω–µ—Ç–∏—á–Ω—ñ_—Ö–≤–æ—Ä–æ–±–∏